Limited Offer
Vestibular Schwannoma, An Issue of Otolaryngologic Clinics of North America
- 1st Edition, Volume 56-3 - May 2, 2023
- Editors: Erika Woodson, Matthew Carlson
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 3 7 0 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 3 7 5 - 1
In this issue of Otolaryngologic Clinics, guest editors Drs. Erika Woodson and Matthew Carlson bring their considerable expertise to the topic of Vestibular Schwannoma. Top experts… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Contains 19 relevant, practice-oriented topics including guiding patients through decision making in sporadic vestibular management; intraoperative cochlear nerve monitoring in sporadic vestibular schwannoma; stereotactic radiosurgery for sporadic vestibular schwannoma; management of complications in vestibular schwannoma surgery; quality of life outcomes for sporadic vestibular schwannoma; and more.
-
Provides in-depth clinical reviews on vestibular schwannoma, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Foreword
- Preface
- Epidemiology and Risk Factors for Development of Sporadic Vestibular Schwannoma
- Key points
- Introduction and epidemiology
- Familial risk
- Cell phone use
- Noise exposure
- Smoking
- Aspirin
- Summary
- Clinics care points
- Disclosure
- Updates on Tumor Biology in Vestibular Schwannoma
- Key points
- Overview of vestibular schwannnoma
- Summary
- Clinics care points
- Disclosure
- Natural History of Hearing Loss in Sporadic Vestibular Schwannoma
- Key points
- Background
- Evaluation
- Progression
- Pathogenesis
- Discussion
- Summary
- Clinics care points
- Declaration of Interests
- Introducing an Evidence-Based Approach to Wait-And-Scan Management of Sporadic Vestibular Schwannoma: Size Threshold Surveillance
- Key points
- Motivation for a paradigm shift in observation management
- Clinically meaningful size thresholds to guide timing of treatment
- Quality of life data and implications for small tumors
- Putting it all together: size threshold surveillance
- Summary
- Clinics care points
- Funding
- Guiding Patients Through Decision-Making in Management of Sporadic Vestibular Schwannoma
- Key points
- Introduction
- Management options for sporadic vestibular schwannoma
- Decision-making criteria in vestibular schwannoma management
- Communication strategies in shared decision-making
- Framing the conversation for shared decision-making
- Cultivating inclusivity in decision-making
- Summary
- Clinics care points
- Intraoperative Cochlear Nerve Monitoring in Vestibular Schwannoma Microsurgery
- Key points
- Introduction
- Hearing preservation vestibular schwannoma microsurgery
- Alternative monitoring methods during microsurgery
- Clinics care points
- Contributions
- Disclosures
- Translabyrinthine Approach for Sporadic Vestibular Schwannoma: Patient Selection, Technical Pearls, and Patient Outcomes
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Declaration of Interests
- Middle Cranial Fossa Approach for Sporadic Vestibular Schwannoma: Patient Selection, Technical Pearls, and Hearing Results
- Key points
- Introduction
- Patient selection
- Surgical technique and pearls
- Complications and risks
- Hearing outcomes
- Summary
- Clinics care points
- Disclosure
- Retrosigmoid Approach for Sporadic Vestibular Schwannoma: Patient Selection, Technical Pearls, and Hearing Results
- Key points
- Introduction, historical context, and background
- Discussion
- Selected hearing preservation results
- Clinics care points
- Disclosure
- Radiation for Sporadic Vestibular Schwannoma: An Update on Modalities, Emphasizing Hearing Loss, Side Effects, and Tumor Control
- Key points
- Introduction
- Definitions
- Techniques
- Hearing results
- Role in treating large tumors
- Summary
- Clinics care points
- Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas
- Key points
- Introduction
- Evaluation
- Management
- Summary
- Clinics care points
- Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons
- Key points
- Introduction
- Clinical trials completed
- Clinical trials in progress
- Future directions
- Clinics care points
- Financial disclosures
- Salvage Management of Vestibular Schwannoma
- Key points
- Introduction
- Surgical failures
- Resection followed by radiosurgery
- Resection followed by resection
- Radiosurgery failures
- Radiosurgery followed by repeat radiosurgery
- Radiosurgery followed by salvage resection
- Summary
- Clinics care points
- Disclosure
- Management of Complications in Vestibular Schwannoma Surgery
- Key points
- Introduction
- Summary
- Declaration of Interests
- Quality of Life in Sporadic Vestibular Schwannoma
- Key points
- The growing centrality of quality of life in sporadic vestibular schwannoma
- Overview of disease-specific quality of life instruments in vestibular schwannoma
- Quality of life outcomes
- Summary
- Clinics care points
- Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II
- Key points
- Introduction
- Sporadic versus neurofibromatosis type 2 vestibular schwannoma
- Vestibular schwannoma treatment options
- Hearing outcomes
- MRI
- Summary
- Clinics care points
- Disclosure
- Advances in Facial Reanimation
- Key points
- Introduction
- Management of the upper third of the face
- Management of the midface and lower face
- Summary
- Financial disclosures
- Conflict of interest
- The Future of Vestibular Schwannoma Management
- Key points
- Introduction
- Diagnosis, Prognosis, and Monitoring
- Biomarkers
- Advanced Imaging
- Patient-Specific Stem Cell-Derived Models
- Treatment
- The Future of Radiation Therapy
- The Future of Microsurgery
- Therapeutic agents
- Immunotherapy
- Gene Therapy
- Summary
- Clinics care points
- Declaration of Interests
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 56-3
- Published: May 2, 2023
- Imprint: Elsevier
- Hardback ISBN: 9780443183706
- eBook ISBN: 9780443183751
EW
Erika Woodson
MC